Loading...

2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

EP.0561

Optimizing Group and Save Testing in Minimal Access Gynecological Surgery

Part of Topic

General gynaecology

OPTIMIZING GROUP AND SAVE TESTING IN MINIMAL ACCESS GYNECOLOGICAL SURGERY

Dr Neha Uddin , Dr Omar Lotfi, Mrs Madhu Kolli

AIM: 

•  Assess the cost-effectiveness and clinical impact of requiring two blood samples for Group and Save before gynaecological procedures.

 • Evaluate whether a risk-based selective approach can enhance preoperative efficiency.

METHODS: 

Design: Retrospective analysis (Oct 2023–Oct 2024).

•  Setting: Aneurin Bevan University Health Board.

•  Procedures: Selected laparoscopic gynaecological surgeries (excluding complex cases).  

•  Focus Areas:  

-Necessity of dual sample collection.  
-Impact on workflow, cost, and patient outcomes.  

Group and Save history, transfusion needs, and single-sample eligibility

RESULTS AND DISCUSSION

•  Records reviews: 75 cases.

•  Dual Testing Usage: 98.6% had two Group and Save tests, despite 81% having a historic sample.

•  Unnecessary Costs & Inefficiency: Routine dual testing led to resource overuse.

•  Pregnancy Factor: 44% had prior pregnancies, requiring two samples.

•  Transfusion Risk: Only 1.3% required transfusion, confirming low-risk procedures.

•  Operational Considerations:  

-Crossmatching feasible within 60 minutes if needed.
-Multi-site operations may face transport delays.

•  No Delays or Cancellations: No cases were affected by invalid Group and Save samples, supporting potential streamlining of testing requirements.

CONCLUSION: 

•  A selective Group and Save approach could eliminate the need for two samples in over half of cases, improving efficiency and reducing costs.  

•  Targeted testing would optimize lab workload, minimize unnecessary blood draws, and support sustainability.

•  Future policies should adopt a risk-based strategy to ensure resource efficiency while maintaining high-quality patient care.



Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.